moxifloxacin has been researched along with midostaurin in 1 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (midostaurin) | Trials (midostaurin) | Recent Studies (post-2010) (midostaurin) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 491 | 36 | 286 |
Protein | Taxonomy | moxifloxacin (IC50) | midostaurin (IC50) |
---|---|---|---|
Aurora kinase A | Homo sapiens (human) | 0.08 | |
Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | 0.142 | |
Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.109 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.25 | |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.1663 | |
Aspartyl/asparaginyl beta-hydroxylase | Homo sapiens (human) | 7.5767 | |
AP2-associated protein kinase 1 | Homo sapiens (human) | 0.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
del Corral, A; Dutreix, C; Harrell, R; Huntsman-Labed, A; Lorenzo, S; Morganroth, J; Wang, Y | 1 |
1 trial(s) available for moxifloxacin and midostaurin
Article | Year |
---|---|
Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers.
Topics: Adolescent; Adult; Antineoplastic Agents; Aza Compounds; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Protein Kinase Inhibitors; Quinolines; Staurosporine; Young Adult | 2012 |